Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of Age

Conditions:   Measles;   Rubella;   Rubella Syndrome, Congenital Interventions:   Biological: Measles-rubella (MR) vaccine at 6 and 9 months;   Biological: Measles-rubella (MR) vaccine at 9 months Sponsors:   Centers for Disease Control and Prevention;   The International Centre for Diarrhoeal Disease Research, Bangladesh;   Ministry of Health and Family Welfare, Bangladesh Not yet recruiting - verified March 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials